Impact of Repeated Ischemic Preconditioning on Hemodynamic and Metabolic Parameters in Chronic Kidney Disease Patients
This study aims to investigate how repeated ischemic preconditioning affects various hemodynamic and metabolic parameters, such as SIRT-1 levels, blood saturation, IL-6 levels, blood pressure, and heart rate, in patients with chronic kidney disease, over a period of 7 days.
Preconditioning with Controlled Ischemia
+ Preconditioning with Controlled Ischemia
+ Preconditioning with Controlled Ischemia
Urogenital Diseases+10
+ Chronic Disease
+ Female Urogenital Diseases and Pregnancy Complications
Prevention Study
Summary
Study start date: July 23, 2026
Actual date on which the first participant was enrolled.This study focuses on understanding how repeated episodes of a process called 'ischemic preconditioning' affect blood pressure, heart rate, and inflammation markers in individuals with various stages of kidney disease. Ischemic preconditioning involves intentionally creating brief periods of reduced blood flow to potentially protect the heart and blood vessels from future damage. This research is important as it could help develop new strategies to prevent complications in people with kidney disease. The study takes place over four days during a hospital stay in the Department of Nephrology, Hypertension, Transplantology and Internal Diseases. During the study, participants will have their blood pressure and heart rate monitored, and a small amount of blood will be taken for laboratory tests. The ischemic preconditioning process involves applying pressure to the lower leg using a blood pressure cuff for four cycles of 5 minutes each. This procedure will be repeated over the next two days. On the final day, blood pressure, heart rate, and blood saturation will be measured again, and another blood sample will be taken for comparison. The study will assess changes in specific markers such as SIRT-1, IL-6, blood saturation, blood pressure, and heart rate, from the beginning to the end of the seven-day period.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.60 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Prevention Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.3 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Group II
Group III
Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 2 locations
Medical University of Lodzi
Lodz, Poland